Quality of Life in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization
10.1155/2016/6120143
Saved in:
Main Authors: | Ahmed, S, De Souza, N.N, Qiao, W, Kasai, M, Keem, L.J, Shelat, V.G |
---|---|
Other Authors: | DUKE-NUS MEDICAL SCHOOL |
Format: | Article |
Published: |
Hindawi Limited
2020
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/179619 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
The use of dual energy computerized tomography to detect residual viable hepatocellular carcinoma after transarterial chemoembolization
by: Pharida Pengwan, et al.
Published: (2020) -
Re-evaluating transarterial chemoembolization for the treatment of Hepatocellular Carcinoma: Consensus recommendations and review by an International Expert Panel
by: Ann Lii Cheng, et al.
Published: (2018) -
Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial
by: Masatoshi Kudo, et al.
Published: (2018) -
Impact of alcohol consumption on treatment outcome of hepatocellular carcinoma patients with viral hepatitis who underwent transarterial chemoembolization
by: Attapon Rattanasupar, et al.
Published: (2022) -
Prognostic score predicting overall survival of patients with intermediate stage of hepatocellular carcinoma after transcatheter transarterial chemoembolization
by: S. Jarupongprapa, et al.
Published: (2020)